Vianney Ortiz-Navarrete Selected Research

class-I restricted T cell-associated molecule

11/2020	Short Disordered Epitope of CRTAM Ig-Like V Domain as a Potential Target for Blocking Antibodies.
1/2019	CRTAM+ NK cells endowed with suppressor properties arise in leukemic bone marrow.
1/2017	Class I-Restricted T Cell-Associated Molecule Is a Marker for IFN-γ-Producing iNKT Cells in Healthy Subjects and Patients with Type 1 Diabetes.
1/2014	Peripheral blood T cells and neutrophils from asthma patients express class-I MHC-restricted T cell-associated molecule.
2/2006	Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vianney Ortiz-Navarrete Research Topics

Disease

5	Infections 01/2021 - 09/2004
4	Neoplasms (Cancer) 01/2021 - 09/2004
4	Salmonella Infections (Salmonellosis) 01/2018 - 07/2005
4	Dengue (Dengue Fever) 03/2016 - 09/2013
3	Virus Diseases (Viral Diseases) 01/2021 - 07/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 12/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 02/2006
2	Inflammation (Inflammations) 01/2020 - 01/2014
2	Necrosis 03/2016 - 10/2003
2	Asthma (Bronchial Asthma) 01/2014 - 07/2013
1	Carcinoma (Carcinomatosis) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Leukemia 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Colitis 11/2020
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Fever (Fevers) 03/2016
1	Severe Dengue 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Coinfection 07/2014
1	Viremia 09/2013
1	Hypersensitivity (Allergy) 07/2013
1	Disease Progression 07/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2012
1	Lymphoma (Lymphomas) 05/2006
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2004
1	Squamous Intraepithelial Lesions 09/2004
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2003

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 01/2021 - 09/2004
5	class-I restricted T cell-associated moleculeIBA 11/2020 - 02/2006
3	Immunoglobulin G (IgG)IBA 03/2016 - 09/2004
3	Immunoglobulin M (IgM)IBA 07/2014 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
2	CytokinesIBA 11/2020 - 03/2016
2	InterferonsIBA 03/2016 - 07/2014
2	InterleukinsIBA 03/2016 - 07/2013
2	LigandsIBA 12/2015 - 10/2003
2	AllergensIBA 01/2014 - 07/2013
1	Oxygen (Dioxygen)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	ADP-ribosyl CyclaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2019
1	InflammasomesIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 03/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	bcr-abl Fusion ProteinsIBA 01/2016
1	Insulin (Novolin)FDA Link 12/2015
1	AntigensIBA 12/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2015
1	Interleukin-17 (Interleukin 17)IBA 07/2013
1	pirfenidoneIBA 03/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2006
1	LipopolysaccharidesIBA 05/2006
1	I-antigenIBA 07/2005
1	EpitopesIBA 09/2004
1	DNA (Deoxyribonucleic Acid)IBA 09/2004
1	Peptides (Polypeptides)IBA 09/2004
1	Immunoglobulin A (IgA)IBA 09/2004
1	Capsid Proteins (Capsid Protein)IBA 09/2004
1	Amino Acids FDA Link 10/2003
1	Glycoproteins (Glycoprotein)IBA 10/2003

Therapy/Procedure

2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 01/2021
1	Therapeutics 01/2021